This was further supported by results showing that human hemokinin-1, a highly selective NK-1R agonist, increases melanoma cell migration by promoting the expression of matrix metalloproteinases 2 and 14, which favor epithelial to mesenchymal transition as demonstrated also in other types of cancers [226,231]. This evidence concerns the gene TACR1 and cancer.